Pro members get same-minute coverage on the stocks they track. Free plans update twice a day.
Get ProCounts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Showing 1 story from the week of 15 Jun
Show allThe items moving the net sentiment the most, by direction and influence.
Macro, commodity, FX and regulatory forces that moved MRK in this range, with the stories behind each.
No indirect-driver news for MRK in this range.
Also monitored for MRK (no news in this range): FDA approvals & trial outcomes, Drug pricing / FDA / IRA.
Sign up free to track MRK, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track MRK for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
How news sentiment on Merck & Co. (MRK) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
